An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long
      COVID-19.

Stellate Ganglion Block to Treat Long COVID 19 Case Series

Long COVID

Long Covid19

Post-COVID-19 Syndrome

Post Acute COVID-19 Syndrome

Dysautonomia

Anosmia

Dysgeusia

Brain Fog

Muscle Pain

Shortness of Breath

Dizziness

Fatigue Post Viral

Cough

Menstrual Cycle Abnormal

Pain

We evaluated the treatment results of 41 patients (18 male and 23 female) aged between 18 and
      89, who received Stellate Ganglion Block (SGB) with Ultrasound guidance for Long COVID-19
      Syndrome. The patients were from the United States and received treatment at our Colorado
      clinics during the period of September to December 2022.Those who responded to our
      post-procedure follow-up calls were included in the study population.

Stellate Ganglion Block

Stellate Ganglion Block to Treat Long COVID-19 Syndrome, A 41 Patient Retrospective Cohort Study

Evaluation of the symptoms response to the Stellate Ganglion Block

Dr. Lisa Pearson, CRNA, NSPMc

Patients who received ultrasound guided Stellate Ganglion block for symptoms of Long COVID in our Colorado clinics.

Metamorphosis LTD

Stellate Ganglion Block to Treat Long COVID 19 Case Series

About this trial

Study ID

Status

Type

Placebo

Accepting

Not accepting

Trial Timing

What is this trial about?

What are the Participation Requirements?

Locations

Location

Status